Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sheel BiotechNSE:SHEEL 18 PS Ratio is 1.09 as of Aug. 02, 2026, which is 8% below its 10-year median of 1.19. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,940 Consumer Packaged Goods companies, Sheel Biotech ranks worse than 58.81% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sheel Biotech's share price is ₹68.00.
Sheel Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹62.61. Hence, Sheel Biotech's PS Ratio for today is 1.09.
The historical rank and industry rank for Sheel Biotech's PS Ratio or its related term are showing as below:
NSE:SHEEL'
s PS Ratio Range Over the Past 10 Years
Min: 0.65 Med: 1.19 Max: 1.73
Current: 1.13
During the past 5 years, Sheel Biotech's highest PS Ratio was 1.73. The lowest was 0.65. And the median was 1.19.
NSE:SHEEL's PS Ratio is ranked worse than 58.81% of 1940
companies
in the Consumer Packaged Goods industry
Industry Median: 0.84
vs NSE:SHEEL: 1.13
During the past 12 months, the average Revenue per Share Growth Rate of Sheel Biotech was 25.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 16.70% per year.
During the past 5 years, Sheel Biotech's highest 3-Year average Revenue per Share Growth Rate was 16.70% per year. The lowest was 12.90% per year. And the median was 14.80% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Sheel Biotech PS Ratio Related Terms
Sheel Biotech PS Ratio Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech PS Ratio Chart
Sheel Biotech Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
PS Ratio
0.00
0.00
0.00
0.00
0.64
Sheel Biotech Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
PS Ratio
0.00
0.00
0.00
0.00
0.64
NSE:SHEEL vs ADM, BG, TSN: PS Ratio Comparison
For the Farm Products subindustry, Sheel Biotech's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sheel Biotech PS Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's PS Ratio distribution charts can be found below:
* The bar in red indicates where Sheel Biotech's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Sheel Biotech's Share Price of today is ₹68.00.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Sheel Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹62.61.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Sheel Biotech (NSE:SHEEL) has a PS Ratio of 1.09 as of Aug. 02, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sheel Biotech and its competitors. This is near median its historical median of 1.19. Over the past decade, Sheel Biotech's PS Ratio has ranged from 0.65 to 1.73. According to the industry distribution chart, Sheel Biotech ranks #1141 out of 1940 companies in the Consumer Packaged Goods industry, placing it in the top 58.8%.
Is Sheel Biotech's PS Ratio too high?
Sheel Biotech's current PS Ratio of 1.09 is near median its 10-year median of 1.19. Over the past 10 years, this metric has ranged from a low of 0.65 to a high of 1.73. The Consumer Packaged Goods industry median PS Ratio is 0.84. Sheel Biotech's value of 1.09 is 29.8% above this industry median. Based on the distribution chart, Sheel Biotech ranks #1141 out of 1940 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's PS Ratio compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Sheel Biotech ranks #1141 out of 1940 companies for PS Ratio. This places Sheel Biotech in the lower half of its industry. The industry median PS Ratio is 0.84. Sheel Biotech's value of 1.09 is 29.8% above this benchmark. Historically, Sheel Biotech's own PS Ratio has ranged from 0.65 to 1.73 over the past decade. While the company's 10-year median is 1.19 vs. the industry median of 0.84, Sheel Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Consumer Packaged Goods company?
The median PS Ratio among Consumer Packaged Goods companies is 0.84, based on 1,940 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sheel Biotech's current PS Ratio of 1.09 is 29.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sheel Biotech and its competitors. For the Consumer Packaged Goods industry, the median PS Ratio is 0.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current PS Ratio is 1.09, which is near median its own 10-year median of 1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current PS Ratio of 1.09. The current PS Ratio is 1.09, which is near median its 10-year median of 1.19 and 29.8% above the Consumer Packaged Goods industry median of 0.84. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current PS Ratio is 1.09 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score
Get the complete analysis for NSE:SHEEL
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
